GENESIS PRIVATE WEALTH, LLC

ASHBURN, VA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 2, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$354.0M2026 Q3
Positions180
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.34.5%

GENESIS PRIVATE WEALTH, LLC reported 180 positions worth $354.0M as of September 30, 2026 (13F filed November 2, 2026). Largest holding: IVV (5.0%). Biggest move: new buy IBIT ($1.7M).

10 / 180 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 IVVIshares Tr$17.8M5.02%23,193———
▸ 2 IWFiShares Russell 1000$15.8M4.47%126,316——-10.9%
▸ 3 IWDIshares Tr$15.5M4.39%62,640——+5.1%
▸ 4 FBNDFidelity Merrimack STR$15.0M4.23%345,605———
▸ 5 CGGRCapital Group Growth$11.7M3.31%247,168———
▸ 6 GLDSPDR Gold$10.7M3.03%28,152——-7.3%
▸ 7 PTRBPgim ETF Tr$9.6M2.73%244,557———
▸ 8 RDVYFirst Tr Exchange$9.3M2.62%118,402———
▸ 9 SCHFSchwab Strategic Tr$8.6M2.42%311,719———
▸ 10 VTEBVanguard Mun BD$8.1M2.29%171,412———

Pro Feature

The remaining 170 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does GENESIS PRIVATE WEALTH, LLC hold as of Q3 2026?

GENESIS PRIVATE WEALTH, LLC reported 180 positions worth $354.0M in its Q3 2026 13F filing. Largest positions: IVV (5.0%), IWF (4.5%), IWD (4.4%), FBND (4.2%) and CGGR (3.3%).

What did GENESIS PRIVATE WEALTH, LLC buy in Q3 2026?

New positions: IBIT, ETHA, AMD, SNOW and BRK-B (14 in all). Added to: CGDV, BSV, IEMG, FBND and FMDE (91 in all).

What did GENESIS PRIVATE WEALTH, LLC sell in Q3 2026?

Reduced: VO, IVV, USHY, HGER and SPGP (62 in all). Sold out entirely: SPY, EXMOC, MNST, MDY and AZN (26 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.